Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Industry:
Biotechnology, Health Care, Life Science
Last Funding Date:
2020-02-26
Investors Number:
4
Technology:
diagnostics
Last Funding Type:
Series B
Headquarters:
Taipei, T'ai-pei, Taiwan
Founded Date:
2015-01-01
Funding Status:
Early Stage Venture
Total Funding:
$10M
Estimated Revenue:
$1M to $10M
Employee Number:
11-50